GUARDALBEN, Emanuele
 Distribuzione geografica
Continente #
NA - Nord America 378
EU - Europa 123
AS - Asia 78
Totale 579
Nazione #
US - Stati Uniti d'America 377
IT - Italia 36
CN - Cina 29
TR - Turchia 21
SG - Singapore 19
DE - Germania 17
BE - Belgio 14
SE - Svezia 14
GB - Regno Unito 13
PL - Polonia 8
FI - Finlandia 6
UA - Ucraina 6
VN - Vietnam 5
ID - Indonesia 4
CZ - Repubblica Ceca 2
FR - Francia 2
AT - Austria 1
CA - Canada 1
EE - Estonia 1
IE - Irlanda 1
LT - Lituania 1
LU - Lussemburgo 1
Totale 579
Città #
Woodbridge 69
Fairfield 58
Ann Arbor 37
Ashburn 30
Ferrara 23
Chandler 22
Seattle 20
Houston 19
Cambridge 17
Santa Clara 16
Singapore 16
Brussels 14
Wilmington 13
Jacksonville 11
Beijing 9
New York 8
Warsaw 8
Izmir 7
Nanjing 7
Helsinki 6
Dong Ket 5
Munich 5
Addison 4
Boardman 4
Bremen 4
Jakarta 4
Milan 4
Princeton 4
Shanghai 3
Shenyang 3
Brno 2
San Diego 2
Tianjin 2
Acton 1
Berlin 1
Changsha 1
Dublin 1
Edinburgh 1
Frankfurt am Main 1
Hebei 1
London 1
Luxembourg 1
Nanchang 1
Ningbo 1
Norwalk 1
Orange 1
Tallinn 1
Toronto 1
Trieste 1
Vienna 1
Totale 473
Nome #
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 193
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 135
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 130
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 129
Totale 587
Categoria #
all - tutte 2.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202065 0 0 0 0 0 13 15 9 14 5 5 4
2020/2021117 0 21 6 5 4 6 3 9 4 43 8 8
2021/202255 4 5 0 2 4 3 9 2 1 5 7 13
2022/202362 6 6 6 7 6 16 4 3 4 0 4 0
2023/202434 3 2 1 2 1 13 1 0 1 0 0 10
2024/202563 4 1 14 11 19 14 0 0 0 0 0 0
Totale 587